Top Abstract Purchase Related
Home
>
Node
>
Subnode

Losartan for the correction of thrombocyte activity in patients suffering from arterial hypertension with metabolic syndrome

Simonenko, V.B.; medvedev, i.N.; Kumova, T.A.

Klinicheskaia Meditsina 86(1): 38-41

2008

ISSN/ISBN: 0023-2149
PMID: 18326282
Document Number: 619167
The aim of the study was to evaluate therapeutic effects of losartan on intravascular thrombocyte activity (ITA) in patients suffering from arterial hypertension with metabolic syndrome (MS). The subjects of the study were 35 patients administered losartan 50 mg a day for 4 months. The dynamics of the following parameters were evaluated: anthropometric parameters, blood lipids, lipid peroxidation in blood plasma and thrombocytes, the anti-oxidative protection of the liquid part of blood and platelets, and ITA. Student criterion was used for statistical analysis. In patients with AH and MS losartan had a positive effect on peroxidation syndrome and optimized ITA. To maintain the positive effects, prolonged administration of losartan is needed. In order to lower body mass in AH patients with MS losartan should be used in combination with non-drug means.

Document emailed within 1 workday
Secure & encrypted payments

Logacheva, I.V.; Shustova, E.N.; Morozova, N.I. 2005: Applicability of fozinopril for correction of basic manifestations of metabolic syndrome in women with arterial hypertension Terapevticheskii Arkhiv 77(3): 60-64
Mamedov, M.N. 2004: Arterial hypertension in a framework of metabolic syndrome: special features and principles of drug correction Kardiologiia 44(4): 95-100
Medvedev, I.N.; Gromnatskiĭ, N.I.; Volobuev, I.V.; Osipova, V.M.; Storozhenko, M.V. 2006: Correction of thrombocyte-vascular hemostasis in metabolic syndrome Klinicheskaia Meditsina 84(1): 46-49
Rihácek, I.; Frána, P.; Schwarz, D.; Plachý, M.; Soucek, M. 2010: The normalized smoothness index and parametric population RDH index of losartan in patients with newly diagnosed hypertension and metabolic syndrome Vnitrni lekarstvi 56(9): 901-909
Erivantseva, T.N.; Olimpieva, S.P.; Chazova, I.E.; Mychka, V.B.; Kilikovskiĭ, V.V. 2006: Metabolic syndrome diagnosis in patients with arterial hypertension and obesity Terapevticheskii Arkhiv 78(4): 9-15
Oleĭnik, V.A.; Zubkova, S.T.; Kamenetskaia, M.S.; Terekhova, G.N. 1995: Nifedipine in the treatment of arterial hypertension in patients with the neuroendocrine-metabolic form of the hypothalamic syndrome Likars'ka Sprava 1995(9-12): 118-120
Cice, G.; Ferrara, L.; Tagliamonte, E.; Russo, P.E.; Di Benedetto, A.; Iacono, A. 1999: Angiotensin-Ii receptor inhibitors in hemodialysed uremia patients with arterial hypertension: candesartan cilexitil versus losartan Cardiologia 44(12): 1071-1076
Beloborodova, A.V.; Morozova, T.E.; Shilov, E.M. 2010: An experience of the use of angiotensin Ii receptor blocker losartan in patients with metabolic syndrome and chronic kidney disease Kardiologiia 50(8): 32-36
Mamedov, M.N.; Gorbunov, V.M.; Kiseleva, N.V.; Oganov, R.G. 2005: Structural-functional changes of myocardium and hemodynamic disturbances in patients with metabolic syndrome: contribution of arterial hypertension in formation of total coronary risk Kardiologiia 45(11): 11-16
Krivosheev, A.B.; Kuimov, A.D.; Khavin, P.P.; Morozova, A.A. 2009: Non-medicamentous correction of metabolic and functional disorders in the biliary tract of patients with metabolic syndrome Voprosy Kurortologii Fizioterapii i Lechebnoi Fizicheskoi Kultury 2009(4): 23-27
Ioffe, I.V.; Lesnoy, V.V. 2016: Correction of Enteral Insufficiency Syndrome in Patients, Suffering Diffuse Peritonitis Klinichna Khirurhiia 2016(2): 15-17
Nesterov, I.I.; Poltavtseva, O.V.; Lazareva, O.A.; Tepliakov, A.T. 2008: Metabolic syndrome: prevalence among outpatients with arterial hypertension, the efficacy of treatment Klinicheskaia Meditsina 86(2): 67-70
Olenskaia, T.L.; Konevalova, N.I.; Rapoport, S.I.; Proshchaev, K.I.; Kozlov, K.L.; Korobov, G.D. 2014: Orthostatic reactions in prognosis of the risks of arterial hypertension as a component of metabolic syndrome Klinicheskaia Meditsina 92(10): 26-32
Pokrovskiĭ, A.V.; Karimov, S.I.; Volynskiĭ, I.D.; Tursunov, B.Z.; Akhtaev, A.R.; Osipov, N.G.; Dobrosel'skaia, I.V.; Karmazanovskiĭ, G.G.; Azizov, K.A. 1993: Radiographic endovascular correction of hyperaldosteronism in patients with arterial hypertension Khirurgiia 1993(10): 34-39
Selivanova, G.V.; Vlasova, T.D.; Moiseeva, O.M.; Krutikov, A.N.; Gordeev, M.L.; Khirmanov, V.N. 1997: Comparative study of the level of cardiomyocyte hypertrophy in patients suffering from ischemic heart disease with normal arterial pressure and in hypertension Tsitologiia 39(10): 938-945
Petukhov, O.I.; Tsygankov, B.D.; Zadionchenko, V.S.; Khrulenko, S.B. 2002: Mental disorders in patients with arterial hypertension with metabolic disturbances Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 102(8): 8-13
Medvedev, I.N.; Gromnatskiĭ, N.I.; Volobuev, I.V.; Osipova, V.M.; Dement'ev, V.I.; Storozhenko, M.V. 2004: Thrombocytic hemostasis in hypertensive patients with metabolic syndrome and its correction with lovastatin Klinicheskaia Meditsina 82(10): 37-41
Shapiro, I.A.; Kalinina, A.M.; Eganian, R.A.; Petrichko, T.A.; P'iankova, E.Iu. 2003: The training programs for correction of the nutritional disturbances behavior in patients with arterial hypertension and diabetes mellitus type 2 Voprosy Pitaniia 72(4): 29-32
Ametov, A.S.; Gubina, E.V. 1999: Metabolic effects of berlipril-5 in patients with non-insulin dependent diabetes mellitus and arterial hypertension Terapevticheskii Arkhiv 71(10): 22-25
Vázquez Vigoa, A.; Vázquez Cruz, A.; Calderín, R.O.; Buchaca, E.F.; Cruz Alvarez, N.M.; Jiménez Paneque, R.; Luño, J. 2003: Metabolic syndrome in patients with essential hypertension Nefrologia: Publicacion Oficial de la Sociedad Espanola Nefrologia 23(5): 423-431